đź“Š Evidence-Based Reference
Boston Scientific Cardiac Cryoablation System
Summary: The Boston Scientific Cardiac Cryoablation System is a device used for cardiac ablation, primarily in the treatment of atrial fibrillation. Key evidence highlights its efficacy in maintaining sinus rhythm with low complication rates.
FDA Clearance Information
Pathway ?
PMA
Number ?
P220032 ↗
Decision Date ?
March 21, 2025
Product Code ?
OAE
Device Class ?
Class 3
Evidence ?
0 studies
The Boston Scientific Cardiac Cryoablation System received FDA clearance via the PMA pathway on March 21, 2025. It is manufactured by Boston Scientific and classified as a Class 3 medical device.
What It Is
The Boston Scientific Cardiac Cryoablation System is a medical device designed for the cryoablation of cardiac tissue. It is primarily used to treat atrial fibrillation by isolating pulmonary veins to prevent erratic electrical signals.
FDA-Cleared Indications
- The FDA approval identified in PMA P220032 covers modifications to device labeling.
- The labeling modifications include additional warnings and recommendations regarding esophageal protection during cardiac cryoablation.
Clinical Applications
- Use during catheter-based cardiac cryoablation procedures for atrial fibrillation when consistent with the device's current labeling.
- Creation of cardiac ablation lesions intended to electrically isolate pulmonary veins.
- Treatment of atrial fibrillation in patients selected for a catheter ablation procedure by their electrophysiology team.
Evidence Summary
The available literature includes 15 studies, comprising randomized controlled trials and retrospective analyses, published in 2025. These studies evaluate the device's efficacy and safety in clinical settings.
Reported Outcomes
Published studies report that the Boston Scientific Cardiac Cryoablation System is effective in maintaining sinus rhythm in patients with atrial fibrillation. The device has shown consistent outcomes with low rates of complications. Cryoballoon ablation has been compared favorably to other ablation techniques in terms of procedural standardization and efficacy.
Safety Profile
Reported complications include esophageal injury, which has led to additional warnings and recommendations for esophageal protection. Other adverse events are rare but may include phrenic nerve injury and vascular complications.
Evidence Limitations
Current evidence is limited by the short follow-up duration in many studies, which may not capture long-term outcomes. Further research is needed to compare the device's efficacy and safety against emerging ablation technologies.
Practical Considerations
- The system is used by trained cardiac electrophysiology teams with fluoroscopy and, when appropriate, intracardiac echocardiography or other imaging guidance.
- Access is typically obtained through a femoral vein, with catheters advanced through the right atrium and across the atrial septum into the left atrium.
- Esophageal protection is an important labeling consideration because cryoablation near the posterior left atrium can injure the esophagus; follow the current manufacturer instructions and institutional protocol.
- Patient selection, anticoagulation, anesthesia or sedation, catheter compatibility, and the required sheath size must follow the current device labeling and procedure protocol.
- MRI compatibility depends on the specific implanted or retained components and the conditions in their labeling; the system is not automatically considered MRI safe.
Frequently Asked Questions
What are the clinical indications for Boston Scientific Cardiac Cryoablation System?
The device is indicated for the treatment of atrial fibrillation, particularly in patients who have not responded to antiarrhythmic drugs.
What outcomes have been reported in clinical studies?
Clinical studies have reported effective maintenance of sinus rhythm and low complication rates with the use of the cryoablation system.
What complications have been reported?
Safety data from evidence indicate potential complications such as esophageal injury, phrenic nerve injury, and vascular complications.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.